To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients-Reference-Cited by-同舟云学术

To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients

Published:2016-03-14 Issue:16 Volume:7 Page:22324-22338
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Piszcz Jaroslaw¹,Armitage Emily G.²,Ferrarini Alessia²,Rupérez Francisco J.²,Kulczynska Agnieszka¹,Bolkun Lukasz¹,Kloczko Janusz¹,Kretowski Adam³,Urbanowicz Alina⁴,Ciborowski Michal³,Barbas Coral²

Affiliation:

1. Department of Haematology, Medical University of Bialystok, Bialystok, Poland

2. CEMBIO, Centre for Metabolomics and Bioanalysis, San Pablo CEU University, Madrid, Spain

3. Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

4. Clinical Oncology and Hematology Department, Provincial Hospital, Suwalki, Poland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting sphingolipid metabolism in chronic lymphocytic leukemia;Clinical and Experimental Medicine;2024-07-30

2. Multiple omics levels of chronic lymphocytic leukemia;Cell Death Discovery;2024-06-21

3. ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia;Leukemia;2023-12-06

4. Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival;Clinical and Translational Medicine;2023-11-30

5. Role of PPAR Receptor and Ligands in the Pathogenesis and Therapy of Hematologic Malignancies;Hemato;2022-06-30